KONJIN
Latest round
- Series A
Last raised
- Sep 2021
Total raised
- Undisclosed
Investors
- 1
About KONJIN
Based in China, established in 2013, KONJIN is an immune cell and stem cell technology developer that focuses on the research and application of immune cells and stem cells in the treatment of diseases to improve the treatment effect of tumor diseases. It built first cells preparation center and first comprehensive cell bank in Sichuan that can be used in storage, R&D and transformation of stem cells. It has many qualifications, such as Sichuan province cell industry standard initiator, national high-tech enterprise. It cooperated with famous institutions such as the Institute of Blood Transfusion of the Chinese Academy of Medical Sciences, Sichuan Provincial People's Hospital, and the General Hospital of the Western Theater Command. The company provides immune cell and stem cell technology. It's entire industry chain model is mainly divided into three sections. upstream cell storage, midstream cell preparation, and downstream cell applications that used in the filed of medical, beauty. The company plans to cell therapy technology research and development and clinical application transformation, promote the company's development.
Who invested in KONJIN
1 investor across 1 round
See all investors in KONJIN
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 29, 2021
Amount
Undisclosed
Investors
Questions about KONJIN
Who invested in KONJIN?
KONJIN has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has KONJIN raised?
KONJIN has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did KONJIN last raise money?
KONJIN's most recent round on record is a Series A, in Sep 2021.
What does KONJIN do?
Based in China, established in 2013, KONJIN is an immune cell and stem cell technology developer that focuses on the research and application of immune cells and stem cells in the treatment of diseases to improve the treatment effect of tumor diseases.
Where is KONJIN headquartered?
KONJIN is headquartered in Chengdu, China.
Which VCs invest in companies like KONJIN?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at KONJIN's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like KONJIN? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.